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TNPO3, transportin-SR2 or Tnp3, a member of the karyopherin β superfamily of proteins, is important for the ability of human
immunodeﬁciencyvirus(HIV-1)toachieveproductiveinfection,asTNPO3depletioninhumancellsleadstoadramaticreduction
of infection. Here we describe and discuss recent ﬁndings suggesting that TNPO3 assists HIV-1 replication in the nucleus and in
fact that TNPO3 may assist PIC maturation in the nucleus. In addition, the viral determinant for the requirement of TNPO3 in
HIV-1 infection is discussed. This paper summarizes the most signiﬁcant recent discoveries about this important host factor and
its role in HIV-1 replication.
1.Introduction
The inﬂuence of the physiological state of cells on retroviral
replication has been known since Temin and Rubin demon-
strated that stopping cell division by X-rays or UV light
prevents Rous sarcoma virus replication [1]. Subsequent
research established the relationship between cell cycle stage
and retroviral infection, revealing that retroviruses do not all
have the same requirements for productive infection [2, 3].
For example, γ-retroviruses such as murine leukemia virus
(MLV) require the host cell to pass through mitosis for eﬃ-
cient infection [4, 5]. The MLV titer decreases at least 10-fold
when infecting cells that are arrested in a non-dividing state.
By contrast, lentiviruses such as HIV-1 show no diﬀerence
in productive infection in dividing versus nondividing cells
[6]. This evidence suggests that lentiviruses have developed
speciﬁc mechanisms for the infection of non-dividing cells.
The ability of HIV-1 to infect non-dividing cells has been
attributed to its capacity to transport the preintegration
complex (PIC) to the nucleus [7, 8]. Translocation of the
HIV-1 PIC into the nucleus is not a simple process as the
PICisalargecomplexthatcontainsintegrase,matrix,capsid,
Vpr, and the viral DNA [7, 9, 10]. Because of its large size, it
isunlikelythatthePICentersthenucleusbypassivediﬀusion
[11]. On the contrary, HIV-1 PIC translocation into the
nucleus must be an active process, possibly making use of
nuclear localization signals [12]. Several viral components
of the PIC such as matrix, Vpr, integrase, and the central
DNA ﬂap have been proposed to be directly involved in
PIC transport into the nucleus. However, evidence in the
literature both supports and refutes a role for these diﬀerent
componentsinnucleartranslocation[13,14].Althoughonly
small amounts of capsid can be found in biochemically
puriﬁed HIV-1 PICs [7, 12, 15, 16], evidence has shown that
capsidplaysanimportantroleintheabilityofHIV-1toinfect
non-dividing cells [3, 17–19] The mechanism used by the
HIV-1PICtoenterthenucleusisnotcompletelyunderstood;
however, it is widely accepted that nuclear import of the
complex is active and energy dependent [8].
In addition to the viral determinants involved in HIV-1
PICnuclearimport,severalhostfactorshavebeenimplicated
in the process: (1) importin 7 [20–22], (2) importin α3[ 23],
(3)importin/importinheterodimer[20,24,25],(4)NUP153
[19, 26, 27], (5) RanBP2 [28], and (6) TNPO3/transportin-
SR2 [29–35].
TNPO3, transportin-SR2 or Tnp3, a member of the
karyopherin β superfamily of proteins, is important for the
ability of HIV-1 to achieve productive infection, as TNPO3
depletion leads to a reduction of HIV-1 infectivity [29–
37]. TNPO3 transports pre-mRNA splicing factors into the
nucleus [38] and recognizes them by binding to phospho-
rylated or nonphosphorylated serine/arginine-rich motifs in2 Molecular Biology International
a RanGTP-dependent manner [39, 40]. TNPO3 is also an
export factor for certain tRNA species, and its yeast ortholog
Mtr10p is an export factor for small ribosomal subunits
[36, 41].
2. Role of TNPO3 in RetroviralInfection
The role of TNPO3 in retroviral infection was initially dis-
covered for HIV-1 [30]; however, more recent work has
demonstrated that TNPO3 is also important for infection
by HIV-2, simian lentiviruses, and, to a lesser extent, equine
infectious anemia virus (EIAV) [31, 32, 37, 42]b u tn o tM L V
orFelineimmunodeﬁciencyvirus(FIV).Intriguingly,simian
immunodeﬁciency viruses (SIVs) exhibited the strongest
dependency on TNPO3 for infection [31, 32, 37, 42].
3. Viral Determinantsfor
the Requirement of TNPO3
3.1. Integrase. A yeast two-hybrid screen identiﬁed TNPO3/
transportin SR-2 as a host protein that interacts with HIV-
1 integrase [29] .T h e s es t u d i e sc o n ﬁ r m e dt h a tT N P O 3d o e s ,
indeed, bind to integrase, suggesting that integrase may be a
key viral determinant for the requirement of TNPO3 in pro-
ductive HIV-1 infection; the same work showed that endoge-
nously expressed TNPO3 in mammalian extracts binds
recombinant HIV-1 but not MLV integrase, which agrees
with the result that TNPO3 is required for HIV-1 infection
but not for MLV [29]. By contrast, the use of recombinant
integrases from diﬀerent retroviruses demonstrated that
bacterially puriﬁed GST-TNPO3 binds to integrase proteins
of HIV-1, MLV, SIVmac, FIV, bovine immunodeﬁciency
virus (BIV), and with less aﬃnity to the integrase of EIAV
[31]; this latter result fails to correlate TNPO3 binding
to integrase with the requirement for infectivity. We also
tested this correlation by using both TNPO3 and viral inte-
grases from mammalian extracts. By pulling-down codon-
optimized integrases from diﬀerent retroviruses expressed
in mammalian cells, we demonstrated that endogenous
TNPO3 binds HIV-1, HIV-2, and SIVmac integrases, which
correlates with the requirement for TNPO3 on infectivity
(Figure 1(a)). Similarly, we observed that the FIV integrase
binds TNPO3, though somewhat weakly. In contrast, the
integrase proteins of EIAV, BIV, and MLV did not bind
TNPO3 in this particular assay (Figure 1(a)). As a positive
control for binding, we demonstrated that, under similar
pull-downconditions,lensepithelium-derivedgrowthfactor
(LEDGF)/p75 bound HIV-1 integrase (Figure 1(b)). Inter-
estingly, we found a positive correlation between TNPO3
bindingandtherequirementforTNPO3inprimatelentiviral
infection (Figure 2). Although western blot is a semiquan-
titative assay, it provides a trend. Overall, in the case of
lentiviruses, a correlation exists between TNPO3 binding to
integrase and the requirement of TNPO3 in infection The
fact that the integrase of FIV interacts with TNPO3 and
that TNPO3 is not required for FIV infection suggests the
existence of two distinct groups of viruses. However, there is
no genetic evidence pointing to integrase as the determinant
for the requirement of TNPO3 during infection. Indeed,
generation of such evidence might not be an easy task, given
that integrase mutants aﬀect multiple stages of the viral life
cycle and complicate clear interpretation of phenotypes [43].
The diﬀerences observed in the interaction of TNPO3
and viral integrases could lie on the origin of the protein
used to measure the interactions. However, it is diﬃcult to
determine which approach is closer to the interactions that
occur inside the cell. In conclusion, TNPO3 binds integrase;
however, the role of this interaction during retroviral infec-
tion is not understood.
3.2. Capsid. In contrast to integrase, genetic and biochem-
ical evidence exists for capsid as a determinant for the
requirement of TNPO3 during HIV-1 infection [31, 36,
37, 44]. By using HIV/MLV chimera viruses on the capsid
protein, the Engelman Lab demonstrated that capsid is
the genetic determinant for the requirement of TNPO3
during infection [31]. Similarly, by extensive mutagenesis
of capsid, the Luban Lab demonstrated that capsid plays a
major role in the requirement for TNPO3 during infection
[44]. TNPO3 was reported to bind soluble capsid [36],
and, more recently, a direct biochemical interaction between
TNPO3 and the HIV-1 core has been demonstrated in our
laboratory [37]. Interestingly, we found that TNPO3 binds
to HIV-1 capsid-nucleocapsid complexes that have been
assembled in vitro, which recapitulate the surface of the
viral core [45]. Altogether, this evidence points out capsid
as an important determinant for the requirement of TNPO3
during productive HIV-1 infection.
4. Role of TNPO3 in HIV-1 Nuclear Import
It is believed that TNPO3 is involved in nuclear import
of the HIV-1 PIC on the basis of the following evidence
[29]: (1) reduction in the number of 2-LTR circles during
HIV-1 infection of TNPO3-depleted cells when compared to
infection of wild-type cells and (2) observation of decreased
nuclear translocation of the PIC in TNPO3-depleted cells
by using an HIV-1 virus containing an IN-GFP fusion
protein. It should be noted, however, that this interpretation
is in question, as more recent work has detected no change
in HIV-1 nuclear entry in the face of TNPO3 depletion,
implying that the block is subsequent to nuclear import [34,
36, 37, 42, 44]; the diﬀerent groups who have investigated
this issue demonstrated that the number of HIV-1 2-LTR
circles in TNPO3-depleted cells was similar when compared
to wild-type cells.
It is important to mention that the measurement of 2-
LTR circles is indirect evidence of PIC nuclear import. After
the viral DNA is imported into the nucleus, it integrates into
the genome; however, a fraction of this viral DNA is ligated
toproducecircularformsbynuclearDNAligases[46].These
products are known as 2-LTR circles, and they are used as
indirectmeasureofnuclearimport.Althoughthe2-LTRisan
indirect measure of PIC nuclear import, this methodology is
widely used as a marker of nuclear import [46].Molecular Biology International 3
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Figure 1: TNPO3 Interaction with retroviral integrases. (a) Human 293T cells, which endogenously express TNPO3, were transfected
with diﬀerent amounts of the indicated mammalian codon-optimized FLAG-tagged retroviral integrases (IN). Twenty-four hours following
transfection cells were lysed in extraction buﬀer (400mM NaCl, 0.5% Triton X-100, 50mM Tris-HCl, pH = 8, 2mM MgCl2,5 %g l y c e r o l
and protease inhibitors (Roche)). Subsequently, extracts were treated with DNAase and precleared using protein-A agarose beads (Sigma) at
4◦C for 1h. Small aliquot of the initial extract was analyzed by Western blot (WB) using anti-TNPO3 antibodies (INPUT). Subsequently, the
extractswere usedtoimmunoprecipitate (IP)thediﬀerentretroviralintegrasesusinganti-FLAGantibodies.FLAG-peptide elutedcomplexes
were analyzed by WB for the presence of TNPO3 and using anti-TNPO3 and anti-FLAG antibodies, respectively. (b) As a positive control
we assayed the known ability of HIV-1 integrase to interact with LEDGF/p75. For this purpose, HA-tagged LEDGF/p75 (LEDGF-HA)
was cotransfected together with FLAG-tagged HIV-1 integrase and immunoprecipitated using anti-FLAG beads. Eluted complexes were
analyzed for the presence of LEDGF/p75 and HIV-1 integrase by WB using anti-HA and anti-FLAG antibodies, respectively. Similar results
were obtained in three independent experiments, and the results of a representative experiment are shown.
Furthermore, no diﬀerence was observed in the levels of
viral DNA nuclear accumulation in TNPO3-depleted cells
relative to control cells following biochemical fractionation,
whichsupportsthe2-LTRﬁndings[36].Altogether,thework
from several independent laboratories suggests that TNPO3
is required when the PIC is in the nucleus.
5. Role of TNPO3 in Nuclear Maturation of
the PIC
The consensus that TNPO3 assists HIV-1 replication in the
nucleus led to testing of the hypothesis that TNPO3 may be
promoting a nuclear maturation step [36]. Remarkably, the4 Molecular Biology International
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Figure 2: Correlation of the ability of TNPO3 to bind diﬀerent
retroviral integrases with the requirement of TNPO3 in retroviral
infection. The ability of TNPO3 to bind to diﬀerent retroviral
integrases was calculated by quantifying the amount of bound
TNPO3 relative to the amount of immunoprecipitated integrase
speciﬁed in Figure 1. The requirement of TNPO3 for the indicated
retrovirus was calculated by the fold inhibition in TNPO3-depleted
cells when 50% of wild-type cells were infected.
Fassati group demonstrated that more capsid accumulates in
the nucleus of TNPO3-depleted cells during HIV-1 infection
relative to wild-type cells. These results indicate that the
presence of TNPO3 in wild-type cells contributes to the
removal of capsid from the nucleus, which may be important
for PIC maturation in the nucleus and integration. In
agreement with a role of TNPO3 in the nucleus, depletion of
TNPO3 altered the selection of chromosomal sites for viral
integration [28].
6. Role of CPSF6in the Abilityof TNPO3 to
AssistHIV-1 Replication
The cleavage and polyadenylation speciﬁcity factor subunit
6 (CPSF6), an SR-protein, is a potential nuclear transport
cargo of TNPO3. Interestingly, expression of a CPSF6 frag-
ment (1-358) lacking the nuclear localization signal blocks
HIV-1 nuclear import [19]; therefore, it is conceivable that
TNPO3 depletion causes accumulation of CPSF6 in the
cytosol and that this accumulation impairs HIV-1 replica-
tion. Furthermore, a virus containing the capsid mutation
N74D is resistant to the replication block imposed by
overexpression of the CPSF6 fragment in the cytosol [19].
Intriguingly, infection of the HIV-1 capsid mutant N74D is
independent of TNPO3. Altogether, these results imply that
the eﬀect of TNPO3-depletion on HIV-1 infection is in part
linked to CPSF6.
Analysis of TNPO3-depleted cells revealed minimal
changes in the distribution of CPSF6 by cytosolic/nuclear
fractionation and immunoﬂuorescence in HeLa cells [37].
These results implied that TNPO3 depletion minimally
changes the localization of CPSF6 and suggest that the eﬀect
of TNPO3 depletion on HIV-1 infection is independent of
a change in CPSF6 localization. However, these results do
not exclude the possibility that CPSF6 plays a role in the
phenotype observed for HIV-1 in TNPO3-depleted cells.
7. Role of TNPO3 in HIV-1 Infection
TNPO3 is a nuclear importer that is important for HIV-1
replication. Two possible viral determinants of the require-
ment for TNPO3 in HIV-1 replication have been postulated,
integrase and capsid [29, 31, 37, 44]. However, compelling
genetic and biochemical evidence has only been found for
capsid [31, 37, 44], and thus it remains a question whether
integraseisstillaplayerintheabilityofTNPO3toassistHIV-
1 replication once infection has taken place. It is possible
that capsid and integrase are jointly playing a role in the
requirement for TNPO3 in HIV-1 replication. However, this
remains to be determined.
Several groups have conﬁrmed the observation that
TNPO3-depletion allows formation of 2-LTR circles during
HIV-1infection[36,37,42,44].Eventhoughformationof2-
LTR circles is an indirect measure of nuclear import, it is one
of the most used tools to determine whether the HIV-1 PIC
has been transported to the nucleus [46]. These experiments
implied that in TNPO3-depleted cells the PIC has been
transported to the nucleus; however, HIV-1 integration did
not occur [29, 34, 36, 37, 44]. This suggested, in turn,
that TNPO3 is assisting some process in the nucleus prior
to integration. In agreement with this idea, it has been
proposed that TNPO3 plays a role in depleting capsid
from the nucleus during infection, which may help PIC
maturation in the nucleus [36]. This model suggests that
small amounts of HIV-1 capsid that remain bound to the
PIC are transported into the nucleus, in agreement with
the observation that capsid is the viral determinant for the
infectionofnondividingcells[17,18].However,experiments
indicate that biochemically puriﬁed PICs contain very little
capsid [7, 12, 15, 16], and in fact the presence of capsid
in the nucleus during HIV-1 infection has not been clearly
established. Future work should attempt to clarify this
exciting possibility.
An alternative hypothesis is that TNPO3 binding to the
HIV-1 core in the cytoplasm aids the ribonucleoprotein
(RNP) complex in a process required only after the complex
enters the nucleus [37]. TNPO3 binding to the HIV-1 core
may assist the maturation of the PIC in the cytosol; however,
assistance provided by TNPO3 to HIV-1 replication in the
cytosol will only be noticed when the complex reaches the
nucleus. For example, 3  processing activity of integrase on
the HIV long terminal repeats (LTRs) has been suggested to
occur in the cytoplasm [7, 47]. It is possible that TNPO3
binding to the HIV-1 core ensures proper 3 -processing of
the viral LTRs in the cytoplasm, which will be important
for viral integration when the complex reaches the nucleus.
Future experiments should test whether TNPO3 depletion
can aﬀect 3 -processing of viral LTRs.Molecular Biology International 5
The discovery of TNPO3 has pushed the HIV-1 research
community to explore in greater depth the mechanism by
which HIV-1 crosses the nuclear envelope and integrates
into the cellular genome. It is expected that this ﬁeld will
grow steadily in the coming years and bring to light novel
mechanistic information and therapeutic opportunities.
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